Recommend a plan for follow-up intensity and frequency and collaboration with other providers. Please use the following references 5 references and 5 more within 5 years. Thanks 1 Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer. Chapter 8, “Mood Disorders” (pp. 347–386) 2 Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications. Chapter 12, “Psychotherapy of Mood Disorders” Chapter 14, “Pharmacological and Somatic Treatments for Major Depressive Disorder” 3 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. \”Depressive Disorders\” 4 Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press. 5 Hagen, B. (Producer). (n.d.-b). Treatment for major depressive disorder in adult Managing depression [Video file]. Mill Valley, CA: Psychotherapy.net.
Depressive disorder is typified by affect changes, as well as changes in cognition and neuro-vegetative functions. This paper will focus on a client with a major depressive disorder. This is because the client presents with symptoms such as sleep disturbance, sadness, impaired social functioning, fatigue, anhedonia etc (Sadock et al, 2014). Accordingly, this paper will present the client’s HPI and the clinical impression, the psychopharmacologic and psychotherapy treatments for the client. Finally, the medical management needs, community support resources and follow-up plan for the client will be discussed.
HPI and Clinical Impression for the Client
MM a 42-year old woman had a history of a recurring major depressive disorder. Her first episode of depression started when she was aged 18 while in college. Treatment for major depressive disorder in adult Five years ago, her depressive symptoms started to manifest gradually, typified by sad mood, irritability, reduced interest in her normal activities, sleep difficulties, psychomotor retardation, fatigue, loss of weight, reduced appetite, as well as recurring suicidal ideation. MM reported that these symptoms had impaired her work and also affected her social functioning. She had become withdrawn because she no longer wanted to socialize with anyone. She also did not attend her work which was a business because she always felt fatigued and did not have any energy. Consequently, MM is currently jobless and has become very isolated. Treatment for major depressive disorder in adult When her depressive symptoms started, she was treated with Lithium and Nefazadone but the two medications did not achieve sustained benefits for MM because her depressive symptoms persisted. Her other medical history includes obesity and high blood pressure. Her current depressive symptoms include sad mood, irritability, reduced interest in her normal activities, sleep difficulties, psychomotor retardation, fatigue, loss of weight, reduced appetite, as well as recurring suicidal ideation. Her depressive symptoms and sad mood has persisted for more than 2 years and hence MM manifests symptoms of major depressive disorder (American Psychiatric Association, 2013).
Psychopharmacologic Treatments
Fluoxetine: The client’s prescription is 20/die mg fluoxetine. Fluoxetine is an SSRI that is recommended by the current guidelines as the primary pharmacologic treatment of major depressive disorder (Jia et al, 2016). Additionally, evidence shows that fluoxetine is effective in treating and managing symptoms of major depressive disorder. The client also has suicidal ideations and fluoxetine has demonstrated significant improvement in suicidal actions in individuals with depression (Jia et al, 2016).
Mirtazapine: This is another medication that is a suitable prescription for the client. This is because Mirtazapine has been used as an add-on treatment for better efficacy. Mirtazapine is an atypical antidepressant that has both noradrenergic and serotonergic antidepressant effects (Stahl, 2014). Treatment for major depressive disorder in adult Mirtazapine also has potent antagonistic effects on various postsynaptic serotonin receptors and is a potent antagonist for histamine receptor. These characteristics of Mirtazapine make it an effective antidepressant. The medication also has sedating effects and hence it is appropriate for this client due to the sleep disturbance she has (Kenji et al, 2016).
Psychotherapy Choices
Interpersonal therapy (IPT): This type of psychotherapy will focus on the client’s relationships with others. The basis of this therapy is that personal relationships are the main cause of ps
Order this paper